Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreaze in Advanced Pancreatic Cancer With Cachexia and Exocrine Pancreatic Insufficiency
NCT04098237Phase 2Active, not recruiting
- Start
- Dec 2020
- Primary completion
- Jan 2024
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pancrelipase in exocrine pancreatic insufficiency (EPI), cachexia. Started Dec 2020; status: active, not recruiting.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)cachexia
Beyond the preview
Go deeper on NCT04098237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098237.